Photodynamic treatment of a secondary vasoproliferative tumour associated with sector retinitis pigmentosa and Usher syndrome type I.
Vasoproliferative tumours may be primary or secondary and present with severe exudation leading to marked visual loss. We describe a 47-year-old man with unilateral secondary vasoproliferative tumour associated with sector retinitis pigmentosa and Usher I syndrome who was successfully treated with a single session of photodynamic treatment. Standard treatment protocol was used except that the treatment duration was doubled. A year after the treatment, the angioma-like tumour vanished and exudation was dramatically reduced. Photodynamic therapy seems to be a minimally invasive and safe technique in eyes with secondary vasoproliferative tumours.
Osman
Saatci A
SA
Aylin
Yaman
Y
Arikan
Gul
G
Celikel
Harika
H
D004396:Coloring Agents; D005451:Fluorescein Angiography; D006391:Hemangioma / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology*; D006801:Humans; D007208:Indocyanine Green; D008297:Male; D008875:Middle Aged; D010778:Photochemotherapy; D017319:Photosensitizing Agents / Q000627:therapeutic use; D011166:Porphyrins / Q000627:therapeutic use; D019572:Retinal Neoplasms / Q000175:diagnosis / Q000188:drug therapy*; D012174:Retinitis Pigmentosa / Q000150:complications*; D052245:Usher Syndromes / Q000150:complications*; D000077362:Verteporfin
D004396:Coloring Agents; D017319:Photosensitizing Agents; D011166:Porphyrins; D000077362:Verteporfin; D007208:Indocyanine Green